Subgroup analysis of the hazard risks of all-cause cause, CV death, and HHF within an 18-month follow-up period based on intention-to-treat analysis. by Chih-Wei Chen (403470)

HR (95% CI) of all-cause mortality and cause specific mortality according to vitamin D status. by Yan Wang (15435)

Subjects:

Image_3_ACEI/ARB Medication During ICU Stay Decrease All-Cause In-hospital Mortality in Critically Ill Patients With Hypertension: A Retrospective Cohort Study Based on Machine Lea... by Boshen Yang (11935403)

“…A significantly lower all-cause in-hospital mortality was observed among patients treated with ACEI/ARB (3.9 vs. 12.7%) as well as a lower 28-day mortality (3.6 vs. 12.2%). …”

Image_2_ACEI/ARB Medication During ICU Stay Decrease All-Cause In-hospital Mortality in Critically Ill Patients With Hypertension: A Retrospective Cohort Study Based on Machine Lea... by Boshen Yang (11935403)

“…A significantly lower all-cause in-hospital mortality was observed among patients treated with ACEI/ARB (3.9 vs. 12.7%) as well as a lower 28-day mortality (3.6 vs. 12.2%). …”

Image_1_ACEI/ARB Medication During ICU Stay Decrease All-Cause In-hospital Mortality in Critically Ill Patients With Hypertension: A Retrospective Cohort Study Based on Machine Lea... by Boshen Yang (11935403)

“…A significantly lower all-cause in-hospital mortality was observed among patients treated with ACEI/ARB (3.9 vs. 12.7%) as well as a lower 28-day mortality (3.6 vs. 12.2%). …”

Table_1_ACEI/ARB Medication During ICU Stay Decrease All-Cause In-hospital Mortality in Critically Ill Patients With Hypertension: A Retrospective Cohort Study Based on Machine Lea... by Boshen Yang (11935403)

“…A significantly lower all-cause in-hospital mortality was observed among patients treated with ACEI/ARB (3.9 vs. 12.7%) as well as a lower 28-day mortality (3.6 vs. 12.2%). …”

Hazard ratios for all-cause mortality. by Oluwadamilola T. Oladeru (13813197)

Subjects:

Key index threshold values of slope instability caused by continuous rainfall intensity. by Li Ronghua (8034416)

Relation between single diagnoses and survival time for diagnoses with significant relations according to multivariate analysis. by Samira Zeynalova (6411407)

Significantly differentially abundant microbial taxa at the genus level. by Yoshiaki Sato (2170141)

Number and shares of accidents according to their cause. by Jaroslav Mašek (22386072)

Subjects:

Druggability evaluation of significant proteins. by Zhangyan Lyu (4070221)

Subjects:

Non-normalized and normalized spatiotemporal parameters between age groups. by Markéta Rygelová (15453112)

Significant variables of DR association from univariate analyses. by Radhika Krishnan (15213756)

Cause-effect analysis diagram. by Xiaodan Xi (2179568)

Risk of fracture with competing risk in denosumab users versus non-users. by Arisa Kobayashi (4379608)

Cumulative incidence for (A) all-cause, (B) cardiovascular cause-specific, and (C) stroke cause-specific mortality from baseline to 70 months. by Xingxing Chen (1569277)

Subjects:

Histogram showing the causes of PPH by referral status (participants can have multiple causes). by Mia Appelbäck (22177424)

Subjects:

Kaplan‒Meier survival analysis curves for all-cause mortality based on trajectories of the RDW. by Riming He (18021538)

Subjects:

Odds ratio analysis of awareness of varicella vaccine and vaccination status for all significant variables based on Chi-squared test. by Lisen Arnheim-Dahlström (505607)